CURRAN, MICHAEL A.,JAISWAL, ASHVIN R.,ZHA, DONGXING,VOO, KUI,TONIATTI, CARLO,PRINZ, BIANKA,BOLAND, NADTHAKARN
申请号：
CA3092695
公开号：
CA3092695A1
申请日:
2019.03.15
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The present disclosure is directed to antibodies binding to PD-L2 and methods of using such antibodies to treat cancers, such as those that express or overexpress PD-L2.
